We have over 100 communities where members discuss oncology, autoimmune diseases (like Sjögren’s and lupus), neurodegenerative diseases and their symptoms (like Parkinson’s, Alzheimer’s and dementia). We also have several communities where caregivers can share tips for coping while caring for a child, parent or spouse.
Please contact us at [email protected] with questions or suggestions.
Some people call it a message board. Others call it a forum or an online support group. We think of it as an online peer-to-peer support group where patients and their families share their experiences and research the latest medical science for their condition.
Smart Patients is an online community for patients and families affected by a variety of illnesses. Here you can learn at your own level about scientific developments related to your condition, share your questions and concerns with other members, and use what you learn in the context of your own life.
We believe patients are the most underutilized resource in healthcare. We’ve watched patients become experts in their conditions — and we see that their knowledge improves the care they receive. With the right tools, you and other patients can do the same.
Sign in to read this conversation or register by entering your email address above.
You can find a full list of communities here. If you don’t find the community you are looking for — or if you’d like to start a new community — let us know. We’d love to help!
185‐minutes post‐treatment. Oral fluid cannabinoid concentrations were measured using ultra‐high performance liquid chromatography‐tandem mass spectrometry. Median (IQR) oral fluid CBD concentrations were highest at
To read the full-text of this research,
you can request a copy directly from the authors.
20‐minutes, quantified as 0.4 (6.0), 15.8 (41.6) and 167 (233) ng·mL‐1 on the 15, 300 and 1500mg CBD treatments, respectively. THC, cannabinol and cannabigerol were not detected in any samples. 259 DW‐5S and 256 DT5000 tests were successfully completed, and no THC‐positive tests were observed. Orally administered CBD does not appear to produce false‐positive (or true‐positive) tests for THC on the DW‐5S and DT5000. The likelihood of an individual who is using a CBD (only) oral formulation being falsely accused of DUIC therefore appears low.